MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-20-2026
IDEXX Laboratories ROCE Ratio 2011-2026 | IDXX
Annual ROCE Ratio IDEXX Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61.76 | 50.7 | 47.53 | 59.48 | 55.69 | 40.57 | 49.93 | 64.07 | 58.27 | 58.75 | 49.84 | 46.2 | 35.47 | 37.66 | 39.77 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 64.07 | 35.47 | 50.38 |
Quarterly ROCE Ratio IDEXX Laboratories
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62.54 | 58.9 | 52.67 | 36.93 | 49.94 | 49.97 | 53.4 | 44.0 | 60.89 | 64.76 | 89.04 | 71.38 | 84.28 | 80.3 | 55.84 | 42.13 | 52.18 | 49.32 | 45.89 | 29.77 | 40.22 | 42.81 | 46.36 | 49.95 | 54.55 | 57.23 | 61.37 | 64.09 | 62.85 | 61.71 | 60.02 | 58.29 | 58.55 | 59.22 | 59.4 | 58.77 | 55.53 | 52.32 | 49.12 | 48.52 | 43.88 | 45.06 | 45.55 | 46.21 | 48.18 | 44.07 | 39.77 | 35.47 | 36.41 | 36.73 | 37.13 | 37.66 | 37.87 | 38.29 | 39.42 | 39.77 | 9.45 | 12.0 | 9.01 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 89.04 | 9.01 | 49.44 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
25.0 | $ 115.62 | 0.06 % | $ 35.1 B |  USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 1.65 | -1.2 % | $ 2.19 M | USA |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 24.98 | 2.13 % | $ 694 M | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M |  Israel |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 21.85 | 2.92 % | $ 1.16 B | USA |
 |
Illumina
ILMN
|
-35.1 | $ 128.52 | 0.5 % | $ 20.4 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 15.6 | -4.35 % | $ 472 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 84.11 | -0.26 % | $ 5.68 B | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 171.23 | 0.86 % | $ 8.49 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 421.37 | 2.64 % | $ 12.2 B | USA |
 |
Guardant Health
GH
|
440.3 | $ 88.5 | -0.46 % | $ 11.1 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 27.54 | 0.25 % | $ 20 B |  Niderland |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Personalis
PSNL
|
-33.64 | $ 5.96 | -2.3 % | $ 353 M | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 1.93 | -2.08 % | $ 8.54 M | USA |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 7.27 | 3.12 % | $ 303 M | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Soleno Therapeutics
SLNO
|
2.09 | $ 52.75 | 0.06 % | $ 2.68 B | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.45 | -0.94 % | $ 2.05 B | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.18 | 1.87 % | $ 5.01 M | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 17.11 | -0.7 % | $ 383 M | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 468.04 | -0.36 % | $ 176 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 103.21 | 1.02 % | $ 8.51 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 263.43 | -0.12 % | $ 21.9 B | USA |
 |
Trinity Biotech plc
TRIB
|
0.08 | $ 0.64 | -0.82 % | $ 61.9 M | Irlanda |
 |
Celcuity
CELC
|
-171.24 | $ 125.68 | 3.84 % | $ 5.88 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 61.0 | 0.1 % | $ 3.65 B | USA |
 |
OpGen
OPGN
|
4.4 | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 8.61 | 3.86 % | $ 1.1 B | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.83 | 1.05 % | $ 447 M | USA |
 |
Natera
NTRA
|
-76.66 | $ 204.39 | 0.31 % | $ 20.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 196.63 | 0.21 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |